Insmed reported $-1.09 in EPS Earnings Per Share for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Eps Change
Acelrx Pharmaceuticals ACRX:US USD -0.94 0.26
Alimera Sciences ALIM:US USD -0.75 0.3
Biomarin Pharmaceutical BMRN:US USD -0.04 0.19
Cytokinetics CYTK:US USD -1.52 1.29
Dbv Technologies DBVT:US USD -0.18 0.15
Dynavax Technologies DVAX:US USD 0.43 0.44
Gilead Sciences GILD:US USD 1.67 0.23
Heron Therapeutics HRTX:US USD -0.38 0.17
Insmed INSM:US USD -1.09 0.29
Mirati Therapeutics MRTX:US USD -3.09 0.09
Novartis NVS:US USD 1.52 0.06
Ophthotech OPHT:US USD -0.35 0.06
Regeneron Pharmaceuticals REGN:US USD 12.56 1.42
Sarepta Therapeutics SRPT:US USD -2.94 0.29
Seattle Genetics SGEN:US USD -1.03 0.3
Ultragenyx Pharmaceutical RARE:US USD -3.5 1.24
Vertex Pharmaceuticals VRTX:US USD 3.76 0.25